Gabapentin for the treatment of acute mania;Gabapentin in der behandlung der akuten manie

Fortschritte der Neurologie Psychiatrie

Volumn 67, Issue 6, 1999, Pages 256-260

  Grunze, H ^a   Erfurth, A ^b   Amann, B ^b   Normann, C ^b   Walden, J ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; DOXEPIN; GABAPENTIN; HALOPERIDOL; LEVOMEPROMAZINE; LITHIUM; LITHIUM CARBONATE; NEUROLEPTIC AGENT; OXAZEPAM; PERAZINE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MIXTURE; DRUG POTENCY; DRUG SAFETY; HUMAN; MANIA;

EID: 0033040759     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994974     Document Type: Article

References (19)

1. Ballenger, J. C., R. M. Post: Carbamazepine in manic-depressive illness: a new treatment. Am. J. Psychiat. 137 (1980) 782-790
2. Bech, P., O. J. Rafaelsen, P. Kramp, T. G. Bolwig: The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 17 (1978) 430-431
3. Bialer, M., S. I. Johannessen, H. J. Kupferberg, R. H. Levy, P. Loiseau, E. Perucca: Progress report on new antiepileptic drugs: a summary of the third Eilat conference. Epilepsy. Res. 25 (1996) 299-319
4. Bowden, C. L., A. M. Brugger, A. C. Swann, J. R. Calabrese, P. G. Janicak, F. Petty, S. C. Dilsaver, J. M. Davis, A. J. Rush, J. G. Small et al.: Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271 (1994) 918-924
5. Bowden, C. L: Role of newer medications for bipolar disorder. J. Clin. Psychopharmacol. 16 (1997) 48-55
6. Bowden, C. L., J. Calabrese, G. Sachs, A. Khan, J. Ascher, D. Rudd, et al.: Lamotrigine in bipolar depression. Proc. of the 15th APA Annual meeting, New research abstracts (1998) 244
7. Bruni, J.: Gabapentin. Can. J. Neurol. Sci. 23 (1996) 10-12
8. Chadwick, D. W.: An overview of the efficacy and tolerability of new antiepileptic drugs. Epilepsia 38 (1997) 59-62
9. Dichter, M. A., J. Brodie: New epileptic drugs. The New England Journal of Medicine 334 (1994) 1583-1590
10. Erfurth, A., C. Kammerer, H. Grunze, C. Normann, J. Walden: An open label study of gabapentin in the treatment of mania. J. Psychiatr. Res. 32 (1998) 261-264
11. Keck, P. E. Jr., S. L. McElroy, K. C. Tugrul, J. A. Bennett: Valproate oral loading in the treatment of acute mania. J. Clin. Psychiatry 54 (1993) 305-308
12. McElroy, S. L., C. A. Soutullo, P. E. Keck Jr., G. F. Kmetz: A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann. Clin. Psych. 9 (1997) 99-103
13. Okuma, T., A. Kishimoto, K. Inoue, H. Matsumoto, A. Ogura, T. Matsishita, T. Nakao, C. Ogura: Antimanic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. - A preliminary report. Folia. Psychiatr. Neurol. Japonica 27 (1973) 283-297
14. Pope, H. G. Jr., S. L. McElroy, P. E. Keck Jr., J. I. Hudson: Valproate in the treatment of acute mania. A placebo-controlled study. Arch. Gen. Psychiatry 48 (1991) 62-68
15. Riva, R., F. Albani, M. Contin, A. Baruzzi: Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations. Clin. Pharmacokinet. 31 (1996) 470-493
16. Schaffer, C. B., L. C. Schaffer: Gabapentin in the treatment of bipolar disorder. Am. J. Psychiatry. 154 (1997) 291-292
17. Stanton, S. P., P. E. Keck, S. L. McElroy: Treatment of acute mania with gabapentin. Am. J. Psychiatry 154 (1997)287
18. Walden, J., B. Hesslinger: Value of old and new anticonvulsants in treatment of psychiatric disease. Fortschr. Neurol. Psychiatr. 63 (1995) 320-335
19. Walden, J., B. Hesslinger, D. van Calker, M. Berger: Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar disorder. Pharmacopsychiatry 29 (1996) 193-195